2	eg total abstinence an intrauterine device a double-barrier method such as condom plus diaphragm with spermicide a contraceptive implant an oral contraceptive or have a vasectomized partner with confirmed azoospermia for at least 4 weeks before dosing throughout the entire study period and for 4 weeks|spermicide[413,423]||intrauterine device[334,353]||||||||9969|9969|spermicide
2	eg total abstinence an intrauterine device a double-barrier method such as condom plus diaphragm with spermicide a contraceptive implant an oral contraceptive or have a vasectomized partner with confirmed azoospermia for at least 4 weeks before dosing throughout the entire study period and for 4 weeks|spermicide[334,353]||||||||||9969|9969|spermicide
2	eg total abstinence an intrauterine device a double-barrier method such as condom plus diaphragm with spermicide a contraceptive implant an oral contraceptive or have a vasectomized partner with confirmed azoospermia for at least 4 weeks before dosing throughout the entire study period and for 4 weeks|contraceptive[426,439]||||||||||64078|64078|contraceptive
2	eg total abstinence an intrauterine device a double-barrier method such as condom plus diaphragm with spermicide a contraceptive implant an oral contraceptive or have a vasectomized partner with confirmed azoospermia for at least 4 weeks before dosing throughout the entire study period and for 4 weeks|oral contraceptive[451,469]||||||||||2821|2821|oral contraceptive
2	eg total abstinence an intrauterine device a double-barrier method such as condom plus diaphragm with spermicide a contraceptive implant an oral contraceptive or have a vasectomized partner with confirmed azoospermia for at least 4 weeks before dosing throughout the entire study period and for 4 weeks|oral contraceptive[334,353]|||||||4 weeks[541,548]|||2821|2821|oral contraceptive
3	after study drug discontinuation If currently abstinent the subject must agree to use a double-barrier method as described above if she becomes sexually active during the study period or for 4 weeks after study drug discontinuation Females who are using hormonal contraceptives must have been on a stable|contraceptives[877,891]|||||||4 weeks[805,812]|||2815|2815|contraceptives
4	dose of the same hormonal contraceptive product for at least 4 weeks before dosing and must continue to use the same contraceptive during the study and for 4 weeks after study drug discontinuation|contraceptive[945,958]|||||||4 weeks[980,987]|||64078|64078|contraceptive
4	dose of the same hormonal contraceptive product for at least 4 weeks before dosing and must continue to use the same contraceptive during the study and for 4 weeks after study drug discontinuation|contraceptive[1036,1049]|||||||4 weeks[1075,1082]|||64078|64078|contraceptive
